Sialorrhea with Neurological Diseases in Oral Medicine Fields: A Narrative Review
Downloads
Background: Sialorrhea also known as drooling, literally means excessive saliva flow. In patients with neurological conditions such as Parkinson's disease, cerebral palsy, and stroke. drooling or sialorrhea conditions can be a problem in their lives. In patients with neurological disorders, they experience impaired coordination of facial and mouth muscle movement. Purpose: To describe a review comprehensive management of sialorrhea in neurological, then quality of life can be improved. Reviews: literature search was done thorough literature search between 2008-2020 was done using Science direct, Pubmed and Google Scholar. Conclusion: Treatment for sialorrhea includes non-medical therapy, medical therapy, botulinum toxin, radiotherapy and surgical treatment. Oral medicine specialist dentists have a role in the care of sialorrhea patients with neurological disorders in terms of oral care related as a result of sialorrhea such as perioral dermatitis.
Pedersen AML, Sí¸rensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018 Sep;45(9):730–46.
Binnal A , Ahmed J , Shenoy N , Denny C ML. Dental Management Of Patients Suffering From Drooling: Review And Update. Int J Adv Res. 2014;2(7):615–8.
Bavikatte G, Sit PL, Hassoon A. Management of drooling of saliva. Br J Med Pract. 2016;5(1).
Dias BLS, Fernandes AR, Maia Filho H de S. Sialorrhea in children with cerebral palsy. J Pediatr (Rio J). 2016;92(6):549–58.
Morgante F, Bavikatte G, Anwar F, Mohamed B. The burden of sialorrhea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®). Ther Adv Neurol Disord. 2019;12:1–21.
Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: Anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel). 2013;5(5):1010–31.
McGeachan AJ, McDermott CJ. Management of oral secretions in neurological disease. Pract Neurol. 2017;17(2):96–103.
González-Fernández M, Daniels SK. Dysphagia in stroke and neurologic disease. Phys Med Rehabil Clin N Am. 2008 Nov;19(4):867–88.
Banfi P, Ticozzi N, Lax A, Guidugli GA. A Review of Options for Treating Sialorrhea in Amyotrophic Lateral Sclerosis. 2015;(C):1–9.
Squires N, Wills A, Rowson J. The management of drooling in adults with neurological conditions. Curr Opin Otolaryngol Head Neck Surg. 2012 Jun;20(3):171–6.
Seppi K, Chaudhuri KR, Coelho M, Fox SH, Uk M, Katzenschlager R, et al. Update on Treatments for Nonmotor Symptoms of Parkinson ' s Disease ” An Evidence-Based Medicine Review. 2019;(December 2018):1–19.
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, et al. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidencebased medicine review. Mov Disord. 2019;34(2):180–98.
Arbouw MEL, Movig KLL, Poels PJE. Glycopyrrolate for sialorrhea in Parkinson disease. 2010;1203–7.
Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farré M. Salivary secretory disorders, inducing drugs, and clinical management. Int J Med Sci. 2015;12(10):811–24.
Isaacson J, Patel S, Torres-Yaghi Y, Pagán F. Sialorrhea in Parkinson's Disease. Toxins (Basel). 2020;12(11):691.
Varley LP, Denieffe S, O'Gorman C, Murphy A, Gooney M. A systematic review of noninvasive and invasive sialorrhea management. J Clin Nurs. 2019 Dec;28(23–24):4190–206.
Hassan BAR, Yusoff ZBM, Othman MAH, Bin S, information is available at the end of the Chapter A. Intech. 2018;1–13.
Villa TG, Sánchez-Pérez Á, Sieiro C. Oral lichen planus: a microbiologist point of view. Int Microbiol. 2021;24(3): 275–89.
Srivanitchapoom P, Pandey S, Hallett M. Parkinsonism and Related Disorders Drooling in Parkinson ' s disease : A review. Park Relat Disord. 2014;20(11):1109–18.
Copyright (c) 2022 Diah Savitri Ernawati, Togu Andrie Simon Pasaribu
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Lisence, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Copyright notice:
IJDM by UNAIR is licensed under a Creative Commons Atribusi 4.0 Internasional.
- The journal allows the author to hold the copyright of the article without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY)
